Enliven Therapeutics, Inc. (ELVN)

44.65 -0.52 (-1.15%) USD  |  NASDAQ  |  Sep 25, 13:21
More

Enliven Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for ELVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Definium Therapeutics, Inc. --
Cocrystal Pharma, Inc. --
CNBX Pharmaceuticals, Inc. --
GB Sciences, Inc. --
Arvinas, Inc. Upgrade